28. (1) In this section, “advertisement” includes an announcement, directory listing or other form of communication similar to an advertisement; “drug services” means one or more of the compounding, dispensing or sale by retail of drugs or the provision of information or advice with respect to drugs.  O. Reg. 451/10, s. 5; O. Reg. 59/11, s. 1 (1, 2). (2) A member shall not, through any medium, publish, display, distribute or use, or permit, directly or indirectly, the publication, display, distribution or use through any medium of, an advertisement relating to drug services that, (a)  is false, misleading or deceptive, whether as a result of the inclusion of information or the omission of information; (b)  is not readily comprehensible to the persons to whom it is directed; (c)  is not dignified and in good taste; (d)  contains anything that cannot be verified; (e)  contains testimonials, comparative statements or endorsements; (f)  contains a reference to a member’s area of practice or to a procedure or treatment available from a member practising in the pharmacy, unless the advertisement discloses whether or not the member has an area of expertise and, if the member does have such an area of expertise, the particular expertise; (g)  contains references to a particular brand of equipment used to assist in providing drug services; (h)  contains information that is not relevant to the choice of a pharmacist; or (i)  contains any representations as to the safety or effectiveness or an indication for use of any drug referred to in Schedule I established by the regulations under the Drug and Pharmacies Regulation Act. (j)  Revoked:  O. Reg. 59/11, s. 1 (4). O. Reg. 451/10, s. 5; O. Reg. 59/11, s. 1 (3, 4). (3) An advertisement by a member that includes price information relating to drugs referred to in Schedule I established by the regulations under the Drug and Pharmacies Regulation Act shall include the price information for at least 15 different drugs, 10 of which each belong to a different one of the following drug classifications: 1.  Anti-infective agents. 2.  Antineoplastic agents. 3.  Autonomic agents. 4.  Blood formation and coagulation drugs. 5.  Cardiovascular drugs. 6.  Central nervous system drugs. 7.  Diagnostic agents. 8.  Electrolytic, caloric and water balance drugs. 9.  Cough preparations. 10.  Eye, ear, nose and throat preparations. 11.  Gastrointestinal drugs. 12.  Gold compounds. 13.  Heavy metal antagonists. 14.  Hormones and substitutes. 15.  Oxytocics. 16.  Skin and mucous membrane preparations. 17.  Spasmolytics. 18.  Unclassified therapeutic agents. 19.  Vitamins.  O. Reg. 451/10, s. 5; O. Reg. 59/11, s. 1 (5). (4) Where an advertisement by a member includes price information relating to drugs referred to in Schedule I established by the regulations under the Drug and Pharmacies Regulation Act, the advertisement shall include at a minimum the following information with respect to each drug: 1.  The quantity of the drug being advertised at the advertised price. 2.  The total cost for the drug to the purchaser including any dispensing fee. 3.  The time period during which the advertised price will be available.  O. Reg. 59/11, s. 1 (6). (5) An advertisement by a member that includes price information relating to drugs referred to in Schedule I established by the regulations under the Drug and Pharmacies Regulation Act shall include, in addition to the price information referred to in subsection (4), the following information with respect to each advertised drug: 1.  The strength of the drug. 2.  The brand name of the drug. 3.  The dosage form of the drug.  O. Reg. 59/11, s. 1 (6). (6) Where an advertisement by a member includes price information relating to drugs referred to in Schedule I established by the regulations under the Drug and Pharmacies Regulation Act, equal prominence shall be given to each drug and, for each of those drugs, equal prominence shall be given to all the information required under subsections (4) and (5).  O. Reg. 59/11, s. 1 (6). (7), (8) Revoked:  O. Reg. 59/11, s. 1 (6). Professional Misconduct re Advertising